Aethlon Medical Operating Margin Growth & History (AEMD)
Aethlon Medical's operating margin was −2,072.05% for fiscal 2023.
View full Aethlon Medical company overviewAethlon Medical annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-03-31 | −2,072.05% | +1470.48 pp |
| 2022 | 2022-03-31 | −3,542.53% | −2345.22 pp |
| 2021 | 2021-03-31 | −1,197.31% | −285.26 pp |
| 2020 | 2020-03-31 | −912.04% | +1700.48 pp |
| 2019 | 2019-03-31 | −2,612.53% | +616.29 pp |
| 2018 | 2018-03-31 | −3,228.82% | −1673.40 pp |
| 2017 | 2017-03-31 | −1,555.41% | −1060.83 pp |
| 2016 | 2016-03-31 | −494.58% | +29.13 pp |
| 2015 | 2015-03-31 | −523.71% | −335.51 pp |
| 2014 | 2014-03-31 | −188.20% | +102.48 pp |
| 2013 | 2013-03-31 | −290.68% | −61.62 pp |
| 2012 | 2012-03-31 | −229.06% | — |
Aethlon Medical quarterly operating margin
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2023 | 2023-03-31 | −431.44% | +28431.76 pp |
| Q4 2022 | 2022-03-31 | −28,863.20% | −22245.89 pp |
| Q3 2022 | 2021-12-31 | −14,768.63% | −14377.44 pp |
| Q2 2022 | 2021-09-30 | −1,522.21% | — |
| Q1 2022 | 2021-06-30 | −1,590.14% | — |
| Q4 2021 | 2021-03-31 | −6,617.30% | −5753.76 pp |
| Q3 2021 | 2020-12-31 | −391.18% | −179.21 pp |
| Q4 2020 | 2020-03-31 | −863.54% | +1125.11 pp |
| Q3 2020 | 2019-12-31 | −211.97% | — |
| Q1 2020 | 2019-06-30 | −5,220.63% | −4487.28 pp |
| Q4 2019 | 2019-03-31 | −1,988.65% | −289.63 pp |
| Q1 2019 | 2018-06-30 | −733.35% | — |
| Q4 2018 | 2018-03-31 | −1,699.01% | — |
| Q3 2018 | 2017-12-31 | −1,555.38% | — |
| Q2 2017 | 2016-09-30 | −574.72% | +22.18 pp |
| Q1 2017 | 2016-06-30 | −24,415.36% | −23849.17 pp |
| Q4 2016 | 2016-03-31 | −530.80% | +39.49 pp |
| Q3 2016 | 2015-12-31 | −360.14% | +2890.99 pp |
| Q2 2016 | 2015-09-30 | −596.90% | −471.41 pp |
| Q1 2016 | 2015-06-30 | −566.20% | +1718.60 pp |
| Q4 2015 | 2015-03-31 | −570.29% | −455.72 pp |
| Q3 2015 | 2014-12-31 | −3,251.12% | −1636.27 pp |
| Q2 2015 | 2014-09-30 | −125.49% | −89.86 pp |
| Q1 2015 | 2014-06-30 | −2,284.79% | −1884.07 pp |
| Q4 2014 | 2014-03-31 | −114.57% | +95.12 pp |
| Q3 2014 | 2013-12-31 | −1,614.85% | −1166.13 pp |
| Q2 2014 | 2013-09-30 | −35.63% | +164.26 pp |
| Q1 2014 | 2013-06-30 | −400.72% | +56.40 pp |
| Q4 2013 | 2013-03-31 | −209.69% | — |
| Q3 2013 | 2012-12-31 | −448.72% | −413.09 pp |
| Q2 2013 | 2012-09-30 | −199.89% | — |
| Q1 2013 | 2012-06-30 | −457.13% | — |
| Q3 2012 | 2011-12-31 | −35.63% | — |
Aethlon Medical operating margin trends
Over the last five fiscal years, Aethlon Medical's operating margin increased from −3,228.82% to −2,072.05%, a change of +1156.77 percentage points. The latest reported quarter, Q4 2023, shows −431.44%.
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aethlon Medical source filings ↗Community posts
Aethlon agrees to North Immunology merger backed by $180 million financing
Aethlon ($AEMD) Medical agreed to an all-stock merger with North Immunology, accompanied by a private placement described as approximately $180 million in gross proceeds. That amount includes the conversion of roughly $34 million of existin ...